Dynamic metabonomic analysis of BALB/c mice with different outcomes after D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure

Liver Transplantation

Volumn 14, Issue 11, 2008, Pages 1620-1631

  Feng, Bo ^a   Wu, Shengming ^b   Lv, Sa ^a   Fang, Junjian ^b   Liu, Feng ^a   Li, Yu ^b   Gao, Yan ^a   Yan, Xianzhong ^b   Dong, Fangting ^b   Wei, Lai ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b National Center of Biomedical Analysis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; GALACTOSAMINE; GLUCOSE; LACTIC ACID; LIPOPOLYSACCHARIDE; PHOSPHATE; UREA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HUMAN; KETOGENESIS; LACTATE BLOOD LEVEL; LIVER FAILURE; MALE; METABOLITE; MOUSE; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TIME OF FLIGHT MASS SPECTROMETRY; UREA BLOOD LEVEL; UREA CYCLE;

ADULT; ANIMALS; CHROMATOGRAPHY, GAS; FEMALE; GALACTOSAMINE; HUMANS; LEAST-SQUARES ANALYSIS; LIPOPOLYSACCHARIDES; LIVER FAILURE, ACUTE; MALE; MASS SPECTROMETRY; METABOLOMICS; MICE; MICE, INBRED BALB C; MIDDLE AGED;

EID: 57849104435     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21578     Document Type: Article

References (39)

1. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005;41:1179-1197.
2. Perkins JD. Acetaminophen sets records in the United States: number 1 analgesic and number 1 cause of acute liver failure. Liver Transpl 2006;12:682-683.
3. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Acute Liver Failure Study Group. Hepatology 2005; 42:1364-1372.
4. Saxena V, Gupta A, Gowda GAN, Saxena R, Yachha SK, Khetrapal CL. 1H-NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed 2006;19:521-526.
5. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol 2004;40:192-197.
6. Riordan S, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000;6:170-173.
7. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000;6: 163-169.
8. Cholongitas EB, Betrossian A, Leandro G, Shaw S, Patch D, Burroughs AK. King's criteria, APACHE II, and SOFA scores in acute liver failure [letter]. Hepatology 2006;43: 881.
9. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999;11:1181-1189.
10. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HW, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med 2002;8:1439-1444.
11. Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, et al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer 2005;113:782-788.
12. Shockcor JP, Holmes E. Metabonomic applications in toxicity screening and disease diagnosis. Curr Top Med Chem 2002;2:35-51.
13. Serkova NJ, Zhang Y, Coatney JL, Hunter L, Wachs ME, Niemann CU, et al. Early detection of graft failure using the blood metabolic profile of a liver recipient. Transplantation 2007;83:517-521.
14. Yu K, Sheng G, Sheng J, Chen Y, Xu W, Liu X, et al. A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus. J Proteome Res 2007;6:2413-2419.
15. Yokoyama T, Banta S, Berthiaume F, Nagrath D, Tompkins RG, Yarmush ML. Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model. Metab Eng 2005;7:88-103.
16. Arai K, Lee K, Berthiaume F, Tompkins RG, Yarmush ML. Intrahepatic amino acid and glucose metabolism in a D-galactosamine -induced rat liver failure model. Hepatology 2001;34:360-371.
17. Clemmesen JO, Hoy CE, Kondrup J, Ott P. Splanchnic metabolism of fuel substrates in acute liver failure. J Hepatol 2000;33:941-948.
18. Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, et al. Metabolic profiling analysis of a D-galactosamine/lipopolysaccha-ride-induced mouse model of fulminant hepatic failure. J Proteome Res 2007;6:2161-2167.
19. Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, et al. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 2002; 35:535-543.
20. Fiehn O, Kopka J, Dörmann P, Altmann T, Trethewey RN, Willmitzer L. Metabolite profiling for plant functional genomics. Nat Biotechnol 2000;18:1157-1161.
21. Wold S, Antti H, Lindgren F, Ohman J. Orthogonal signal correction of near-infrared spectra. Chemometr Intell Lab 1998;44:175-185.
22. Holmes E, Antti H. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst 2002;127:1549-1557.
23. Holmes E, Tsang TM, Huang JT, Leweke FM, Koethe D, Gerth CW, et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 2006;3:e327.
24. Pohjanen E, Thysell E, Jonsson P, Eklund C, Silfver A, Carlsson IB, et al. A multivariate screening strategy for investigating metabolic effects of strenuous physical exercise in human serum. J Proteome Res 2007;6:2113-2120.
25. Dunn WB, Ellis DI. Metabolomics: current analytical platforms and methodologies. Trends Analyt Chem 2005;24: 285-294.
26. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 1989;9:594-601.
27. Ott P, Clemmesen O, Larsen FS. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int 2005;47:13-18.
28. Rose C, Michalak A, Rao KV, Quack G, Kircheis G, Butterworth RF. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 1999;30:636-640.
29. Maezono K, Kajiwara K, Matawatari K, Shinkai A, Torii K, Maki T. Alanine protects liver from injury caused by D-galactosamine and CCl4. Hepatology 1996;24:185-191.
30. Shimomura Y, Murakami T, Nagasaki M, Honda T, Goto H, Kotake K, et al. Regulation of branched-chain amino acid metabolism and pharmacological effects of branched-chain amino acids. Hepatol Res 2004;30S:3-8.
31. Honda T, Fukuda Y, Nakano I, Katano Y, Goto H, Sato Y, et al. Effects of liver failure on branched-chain α-keto acid dehydrogenase complex in rat liver and muscle: comparison between acute and chronic liver failure. J Hepatol 2004;40:439-445.
32. Ferencikova R, Cervinkova Z, Drahota Z. Hepatotoxic effect of D-galactosamine and protective role of lipid emulsion. Physiol Res 2003;52:73-78.
33. Nakamura N, Kamiyama Y, Takai S, Kamiya T, Imamura A, Matsui Y, et al. Ex vivo liver perfusion with arterial blood from a pig with ischemic liver failure. Artif Organs 1999;23:153-160.
34. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996;224:97-102.
35. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999;354:505-508.
36. Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [1H-13C] nuclear magnetic resonance study. Hepatology 2003;37:420-428.
37. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl 2003;9:248-253.
38. Shakil AO. Predicting the outcome of fulminant hepatic failure. Liver Transpl 2005;11:1028-1030.
39. MacQuillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11:1073-1079.